World-first use of base-edited CAR T cells to treat resistant leukaemia

16 December 2022

Cancer patient

A 13-year-old girl with relapsed T cell leukaemia has been given base-edited T cells in a world-first use of a base-edited cell therapy, in a ‘bench-to-bedside’ collaboration between UCL and Great Ormond Street Hospital for Children (GOSH).

UCLB is supporting the team securing IP protection for the underlying technology.

Read the full story from UCL.

Read the full story from BBC.